These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 25011684)

  • 21. Histone deacetylase 8 inhibition suppresses mantle cell lymphoma viability while preserving natural killer cell function.
    Watters JM; Wright G; Smith MA; Shah B; Wright KL
    Biochem Biophys Res Commun; 2021 Jan; 534():773-779. PubMed ID: 33190829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histone deacetylases inhibitor sodium butyrate inhibits JAK2/STAT signaling through upregulation of SOCS1 and SOCS3 mediated by HDAC8 inhibition in myeloproliferative neoplasms.
    Gao SM; Chen CQ; Wang LY; Hong LL; Wu JB; Dong PH; Yu FJ
    Exp Hematol; 2013 Mar; 41(3):261-70.e4. PubMed ID: 23111066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of trichostatin A on HDAC8 expression, proliferation and cell cycle of Molt-4 cells.
    He J; Liu H; Chen Y
    J Huazhong Univ Sci Technolog Med Sci; 2006; 26(5):531-3. PubMed ID: 17219959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The structural requirements of histone deacetylase inhibitors: C4-modified SAHA analogs display dual HDAC6/HDAC8 selectivity.
    Negmeldin AT; Knoff JR; Pflum MKH
    Eur J Med Chem; 2018 Jan; 143():1790-1806. PubMed ID: 29150330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the Therapeutic Potential of the Novel Isotype Specific HDAC Inhibitor 4SC-202 in Urothelial Carcinoma Cell Lines.
    Pinkerneil M; Hoffmann MJ; Kohlhof H; Schulz WA; Niegisch G
    Target Oncol; 2016 Dec; 11(6):783-798. PubMed ID: 27250763
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HDAC8 overexpression in mesenchymal stromal cells from JAK2+ myeloproliferative neoplasms: a new therapeutic target?
    Ramos TL; Sánchez-Abarca LI; Redondo A; Hernández-Hernández Á; Almeida AM; Puig N; Rodríguez C; Ortega R; Preciado S; Rico A; Muntión S; Porras JRG; Del Cañizo C; Sánchez-Guijo F
    Oncotarget; 2017 Apr; 8(17):28187-28202. PubMed ID: 28390197
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aryl hydrocarbon receptor regulates histone deacetylase 8 expression to repress tumor suppressive activity in hepatocellular carcinoma.
    Wang LT; Chiou SS; Chai CY; Hsi E; Wang SN; Huang SK; Hsu SH
    Oncotarget; 2017 Jan; 8(5):7489-7501. PubMed ID: 27283490
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design, synthesis, biological evaluation and molecular docking study of arylcarboxamido piperidine and piperazine-based hydroxamates as potential HDAC8 inhibitors with promising anticancer activity.
    Trivedi P; Adhikari N; Amin SA; Bobde Y; Ganesh R; Jha T; Ghosh B
    Eur J Pharm Sci; 2019 Oct; 138():105046. PubMed ID: 31421254
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hydroxamic acid derivatives as HDAC1, HDAC6 and HDAC8 inhibitors with antiproliferative activity in cancer cell lines.
    Sixto-López Y; Gómez-Vidal JA; de Pedro N; Bello M; Rosales-Hernández MC; Correa-Basurto J
    Sci Rep; 2020 Jun; 10(1):10462. PubMed ID: 32591593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery of meta-sulfamoyl N-hydroxybenzamides as HDAC8 selective inhibitors.
    Zhao C; Zang J; Ding Q; Inks ES; Xu W; Chou CJ; Zhang Y
    Eur J Med Chem; 2018 Apr; 150():282-291. PubMed ID: 29533873
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The inhibition of histone deacetylase 8 suppresses proliferation and inhibits apoptosis in gastric adenocarcinoma.
    Song S; Wang Y; Xu P; Yang R; Ma Z; Liang S; Zhang G
    Int J Oncol; 2015 Nov; 47(5):1819-28. PubMed ID: 26412386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Histone deacetylase 8 regulates cortactin deacetylation and contraction in smooth muscle tissues.
    Li J; Chen S; Cleary RA; Wang R; Gannon OJ; Seto E; Tang DD
    Am J Physiol Cell Physiol; 2014 Aug; 307(3):C288-95. PubMed ID: 24920679
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective inhibition of HDAC8 decreases neuroblastoma growth in vitro and in vivo and enhances retinoic acid-mediated differentiation.
    Rettig I; Koeneke E; Trippel F; Mueller WC; Burhenne J; Kopp-Schneider A; Fabian J; Schober A; Fernekorn U; von Deimling A; Deubzer HE; Milde T; Witt O; Oehme I
    Cell Death Dis; 2015 Feb; 6(2):e1657. PubMed ID: 25695609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HDAC8-mediated epigenetic reprogramming plays a key role in resistance to anthrax lethal toxin-induced pyroptosis in macrophages.
    Ha SD; Han CY; Reid C; Kim SO
    J Immunol; 2014 Aug; 193(3):1333-43. PubMed ID: 24973453
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of Histone Deacetylase 8 (HDAC8) Selective Inhibition Reveals Specific Active Site Structural and Functional Determinants.
    Marek M; Shaik TB; Heimburg T; Chakrabarti A; Lancelot J; Ramos-Morales E; Da Veiga C; Kalinin D; Melesina J; Robaa D; Schmidtkunz K; Suzuki T; Holl R; Ennifar E; Pierce RJ; Jung M; Sippl W; Romier C
    J Med Chem; 2018 Nov; 61(22):10000-10016. PubMed ID: 30347148
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A kinome-wide RNAi screen identifies ALK as a target to sensitize neuroblastoma cells for HDAC8-inhibitor treatment.
    Shen J; Najafi S; Stäble S; Fabian J; Koeneke E; Kolbinger FR; Wrobel JK; Meder B; Distel M; Heimburg T; Sippl W; Jung M; Peterziel H; Kranz D; Boutros M; Westermann F; Witt O; Oehme I
    Cell Death Differ; 2018 Dec; 25(12):2053-2070. PubMed ID: 29515255
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HDAC8, A Potential Therapeutic Target for the Treatment of Malignant Peripheral Nerve Sheath Tumors (MPNST).
    Lopez G; Bill KL; Bid HK; Braggio D; Constantino D; Prudner B; Zewdu A; Batte K; Lev D; Pollock RE
    PLoS One; 2015; 10(7):e0133302. PubMed ID: 26200462
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting histone deacetylase 8 as a therapeutic approach to cancer and neurodegenerative diseases.
    Chakrabarti A; Melesina J; Kolbinger FR; Oehme I; Senger J; Witt O; Sippl W; Jung M
    Future Med Chem; 2016 Sep; 8(13):1609-34. PubMed ID: 27572818
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The clinical significance of histone deacetylase-8 in human breast cancer.
    Rahmani G; Sameri S; Abbasi N; Abdi M; Najafi R
    Pathol Res Pract; 2021 Apr; 220():153396. PubMed ID: 33691240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The HDAC6/8/10 inhibitor TH34 induces DNA damage-mediated cell death in human high-grade neuroblastoma cell lines.
    Kolbinger FR; Koeneke E; Ridinger J; Heimburg T; Müller M; Bayer T; Sippl W; Jung M; Gunkel N; Miller AK; Westermann F; Witt O; Oehme I
    Arch Toxicol; 2018 Aug; 92(8):2649-2664. PubMed ID: 29947893
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.